B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells (Q29620717)
Jump to navigation
Jump to search
scientific article (publication date: 22 March 2012)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells |
scientific article (publication date: 22 March 2012) |
Statements
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells (English)
Rosenberg SA
Kochenderfer JN
Dudley ME
Feldman SA
Wilson WH
Spaner DE
Maric I
Stetler-Stevenson M
Phan GQ
Hughes MS
Sherry RM
Yang JC
Kammula US
Devillier L
Carpenter R
Nathan DA
Morgan RA
Laurencot C
22 March 2012
119
2709-20
12
1 reference
1 reference
1 reference
1 reference
1 reference